written on 15.04.2014
Tags:
,

Roche cancer drugs Perjeta and Kadcyla drive strong Q1 results

TAGS: ,

Swiss drug giant Roche has hit the ground running in 2014, announcing today that quick uptake of its new cancer drugs helped drive first-quarter sales up 5% year-over-year in constant currencies to 11.5 billion Swiss francs ($13 billion).

Latest Report